Pharmaceuticals, Biotechnology and Life Sciences
Neovacs, a player in active immunotherapy for the treatment of autoimmune diseases, has enroled the first U.S. patient in its international Phase IIb clinical study of IFNalpha Kinoid in lupus.
Amryt has received orphan drug designation from U.S. Food and Drug Administration (FDA) for its drug compound…
Mereo BioPharma has appointed Richard CM Jones as Chief Financial Officer
The first data analysis of the NKR-2 Phase I trial, run by the Belgia’s biopharmaceutical company Celyad, shows encouraging results
Professor Gerard Evan, FRS, has joined Scientific Advisory Board of Avacta Group, the developer of Affimer biotherapeutics and research reagents.
The primary objective is to determine the effect of daily oral administration of elafibranor on serum alkaline phosphatase (ALP) in these patients, based on relative change versus placebo.
Cardinal Health has announced on Thursday that the board of directors approved a regular quarterly dividend…
LEO Pharma and MorphoSys AG have entered into a strategic alliance for the discovery and development of therapeutic antibodies for the treatment…
Mereo reports positive outcome of its phase 1 study of acute exacerbations of COPD drug
GE Healthcare and Valneva have joined forces to create cell culture medium for vaccine